Plus Therapeutics Inc. (PSTV)
NASDAQ: PSTV
· Real-Time Price · USD
0.68
-0.00 (-0.54%)
At close: Oct 01, 2025, 3:48 PM
Plus Therapeutics Revenue Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
|---|---|---|---|---|---|---|
| Grant Revenue | 1.46M | 1.28M | 1.24M | 506K | 151K | 73K |
| Grant Revenue Growth | +13.84% | +3.15% | +145.06% | +235.10% | +106.85% | n/a |
Revenue by Geography
| Period Ending | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Sep 30, 2014 | Jun 30, 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Americas Revenue | 64K | 44K | 199K | 6K | 45K | 30K | 112K | 55K | 148K | 266K | 79K | 356K | 235K | 2K | 120K | 272K | 605K | 60K | 1.26M |
| Americas Revenue Growth | +45.45% | -77.89% | +3216.67% | -86.67% | +50.00% | -73.21% | +103.64% | -62.84% | -44.36% | +236.71% | -77.81% | +51.49% | +11650.00% | -98.33% | -55.88% | -55.04% | +908.33% | -95.25% | n/a |
| Asia Pacific Revenue | 70K | 5K | 10K | 16K | 18K | 2K | 58K | 5K | 11K | 55K | 1K | 6K | n/a | 986K | 120K | 662K | n/a | n/a | n/a |
| Asia Pacific Revenue Growth | +1300.00% | -50.00% | -37.50% | -11.11% | +800.00% | -96.55% | +1060.00% | -54.55% | -80.00% | +5400.00% | -83.33% | n/a | -100.00% | +721.67% | -81.87% | n/a | n/a | n/a | n/a |
| E M E A Revenue | 150K | 8K | 114K | 57K | 90K | 140K | 18K | 74K | 112K | 98K | 76K | 74K | 966K | n/a | 451K | 352K | n/a | n/a | n/a |
| E M E A Revenue Growth | +1775.00% | -92.98% | +100.00% | -36.67% | -35.71% | +677.78% | -75.68% | -33.93% | +14.29% | +28.95% | +2.70% | -92.34% | n/a | n/a | +28.12% | n/a | n/a | n/a | n/a |
| Japan Revenue | 419K | 365K | 535K | 581K | 578K | 490K | 279K | 835K | 320K | 1.05M | 575K | 690K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Japan Revenue Growth | +14.79% | -31.78% | -7.92% | +0.52% | +17.96% | +75.63% | -66.59% | +160.94% | -69.44% | +82.09% | -16.67% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 1.68M | 2.66M | 3.13M | 2.4M | 2.2M | 2.21M | 2.38M | 2M | 1.92M | 2.25M | 3.58M | 2.22M | 2.29M | 2.14M | 2.04M | 1.99M | 1.47M | 1.35M | 2.3M | 1.06M | 1.43M | 1.62M | 1.67M | 1.17M | 972K | 1.94M | 1.5M | 1.94M | 1.99M | 2.92M | 2.13M | 2.63M | 3.38M | 3.05M | 2.81M | 2.83M | 3.22M | 3.32M | 2.71M | 2.94M | 3.45M | 3.34M |
| Selling, General, and Administrative Revenue Growth | -36.72% | -14.97% | +30.41% | +8.81% | -0.45% | -6.98% | +19.07% | +3.85% | -14.30% | -37.38% | +61.34% | -2.93% | +6.91% | +4.85% | +2.61% | +35.47% | +8.65% | -41.19% | +116.89% | -25.82% | -11.68% | -3.23% | +42.91% | +20.37% | -49.79% | +28.89% | -22.54% | -2.76% | -31.76% | +37.05% | -18.78% | -22.38% | +10.99% | +8.55% | -0.78% | -12.06% | -3.13% | +22.73% | -7.83% | -14.82% | +3.27% | n/a |
| Research and Development Revenue | 1.25M | 1.76M | 2.19M | 2.86M | 2.77M | 2.76M | 2.79M | 2.49M | 1.42M | 2.98M | 2.14M | 2.94M | 2.83M | 1.78M | 1.85M | 1.49M | 1.11M | 1.13M | 1.1M | 336K | 1.11M | 941K | 1.73M | 921K | 1.29M | 1.85M | 2.26M | 1.92M | 1.95M | 2.5M | 2.39M | 3M | 2.99M | 4.97M | 2.86M | 3.96M | 5.25M | 4.13M | 4.64M | 4.35M | 6.05M | 3.96M |
| Research and Development Revenue Growth | -29.04% | -19.67% | -23.51% | +3.07% | +0.36% | -1.11% | +12.07% | +75.56% | -52.40% | +39.52% | -27.40% | +4.03% | +58.60% | -3.46% | +24.01% | +34.81% | -1.86% | +2.83% | +226.19% | -69.68% | +17.75% | -45.58% | +87.73% | -28.55% | -30.17% | -18.17% | +17.75% | -1.79% | -21.93% | +4.39% | -20.31% | +0.40% | -39.86% | +73.77% | -27.70% | -24.53% | +27.14% | -11.00% | +6.55% | -28.04% | +52.61% | n/a |